chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About 5 minutes after receiving the Moderna vaccine in his left deltoid. Patient appeared to have a mild spasm of facial muscles and unresponsive for about 20-30 seconds. when the patient came to, he began sweating profusely, followed by chills and vomited x1. paramedics came to evaluate. Blood pressure 122/86, SpO2 100%, heart rate 70. Paramedics released patient to go home when feeling ok to do so.
felt like I was getting a cold; migraines; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non-HCP) from medical information team. The reporter is the patient. A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; Unknown manufacturer), for COVID-19 Immunization. The following information was reported: NASOPHARYNGITIS (non-serious), outcome "unknown", described as "felt like I was getting a cold"; MIGRAINE (non-serious), outcome "unknown", described as "migraines".  Additional information: On Saturday or Friday we went to get vaccinated in (Place name withheld), we got vaccinated and the night of the vaccine, we got vaccinated at about 7. Of the 4 that we got vaccinated, because we got all vaccinated, the patient also felt like she was getting a cold. The patient read a little bit and saw that could be a side effect. Aside from the sore throat, he had very strong migraines and she did too, but the patient know that headaches are associated with the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Administered the Moderna Covid-19 vaccine which was beyond the use date to patient; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the Moderna Covid-19 vaccine which was beyond the use date to patient) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 067F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 ml. On 10-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the Moderna Covid-19 vaccine which was beyond the use date to patient). On 10-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Administered the Moderna Covid-19 vaccine which was beyond the use date to patient) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No other medications were provided. No treatment medications were reported.  Pharmacist's stated that the beyond the use date is 09Dec2021 at 10:00PM. Administered the vaccine from 10Dec2021-13Dec2021.
Nausea Vomiting Fatigue Muscle aches Joint aches Swollen Lymph nodes in both armpits; more severe swelling on injection side.
Systemic: pain around collarbone area-Mild, Additional Details: Patient says he felt pain in collarbone area after the vaccine.  He said it was mild, but he felt some pain there
clavicular nodules; This is a spontaneous report received from non-contactable reporter(s) (Physician).  An adult patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NODULE (non-serious), outcome "unknown", described as "clavicular nodules".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient finished her 15 minutes wait and made her way the vehicle.  Shortly after reaching the vehicle was feeling short of breath.  Rapid response team from hospital came out and transported her to the emergency room.  Most current nursing note as of 20 minutes ago,    "pt complains of chest pains sob difficulty swallowing and weakness. pt is AA+Ox 4 and has a room air sat of 98% rr of 22, hr of 71."
he mentioned that he can easily breathe and some pain in his shoulders were relieved; This is a spontaneous report received from a contactable reporter(s) (Other HCP) for a Pfizer sponsored program. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 18Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Breathing difficult" (unspecified if ongoing); "Pain in shoulders" (unspecified if ongoing); "surgery" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose number -1), for COVID-19 immunization. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "unknown", described as "he mentioned that he can easily breathe and some pain in his shoulders were relieved".  Additional information: Patient had a favourable effect from the vaccine. Right after the second dose ,he praised the vaccine because it made it easier for him to breathe.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
PFizer covid vaccine when diluting it put 0.2ml solution instead of 2.2 ml
Hep B v #1 R deltoid on 2/14/03. Started swelling and redness at inj area on next day progressed to 3 1/2" x 3 1/2", erythema with induration/warmth. No systemic effects.
In September of 2022 I had abdominal pain at 5 in the afternoon. It continued and migrated to the lower right quadrant. It was more of belly button pain on my right side, and I went to the ER. I had a CAT scan and found I had severe appendicitis. This was on September 7th at 11PM and I had surgery that next day at 1AM in the morning. Now I feel great and perfect.
Expiration Date 6/30/2020. Date given 10/09/2020. 13 weeks past expiration date. Vaccine for 2019 flu? HCP working in hospital in NICU.
Patient has injection site reaction of erythema, increased warmth and induration that began the same day but continued to worsen and was present 9 days post vaccine administration
fever, dyspnea, exanthem, pharyngitis  medical records not available for other info  presume dx strept throat unrelated to vaccination
Approximately nine hours after receiving the vaccine I began feeling fatigue in my muscles and joints. Within a half hour I start to feel cold and used a heating blanket to warm up. Despite being under a heating blanket, I began shivering and feeling pain and soreness in my muscles and joints.  The shivering became severe and the pain increased. The shivering went on for about an hour and a half and finally started to subside. I was able to fall asleep, but woke up  again about 30 minutes later and started to feel hot. I had a fever of 102.6, but felt like my insides were on fire. That went away approximately three hours later. I am still feeling a lot of fatigue,  it my temperature seems to have leveled out.
Rash on ankles, elbows, arms, and legs.  C/o rash being itchy; 0 trouble breathing.
5 cm diam. itching, redness, induration at the site; started about 24 hours after injection; DTAP & IPV administered in that arm; today less induration, still itching & erythema.
Information has been received from a pharmacist referring to a 68 years old female patient. The patient had no drug reactions/allergies. On 12-FEB-2016 the patient was vaccinated with a dose of ZOSTAVAX (lot # L011533, expiration 03-JUL-2016, 0.65 ml) subcutaneously. Concomitant medication included unspecified blood pressure medicine. In February 2016, the patient developed red and hardened area around injection site after receiving ZOSTAVAX. No treatment was given for the events. The patient did not seek for medical attention. The outcome of the event was unknown. Causality was not reported. Additional information has been requested.
pt recv vax & devel high fever & mental retardation the same day;the reporter indicated that relative suffered brain damage & has the mental development of a 2yr old;
developed a prurtic erythematous rash on torso, head and extremities that has peristed,  she is uncertain how long after vaccination started, but thinks relatively soon and has persisted
Itching/redness. I told the patient to take loratadine 10mg (she had to go to work) and try a cold compress. Patient said she had put hydrocortisone on it.
feels physically warm; tired; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP) from a sales representative.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FEELING HOT (non-serious), outcome "unknown", described as "feels physically warm"; FATIGUE (non-serious), outcome "unknown", described as "tired".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Within a few hours of vaccination I had mild symptoms; sore arm, bone ache, rapid heartrate (briefly), strange hallucinating dream.  Seven days following the injection, arm became sore again, developed rash, hot, sore to touch and movement.
had deep muscle pain at the injection site that comes and goes and often wakes at night; Initial information received  on 23-Jan-2023 regarding an unsolicited valid non-serious case received from a consumer/non-healthcare professional.  This case involves a 73 years old female patient who had deep muscle pain at the injection site that comes and goes and often wakes at night while receiving vaccine influenza quadrival a-b high dose hv vaccine [fluzone high-dose quadrivalent].  The patient's past medical history, medical treatment(s), concomitant medication (s) and family history were not provided.   On 28-Nov-2022, the patient had received 0.7ml QD (daily) dose of suspect influenza quadrival a-b high dose hv vaccine lot number not reported via intramuscular route in the left deltoid (formulation, strength, expiration date: not provided) as Immunization.  On 28-Nov-2022 the patient had developed a non-serious deep muscle pain at the injection site that comes and goes and often wakes at night (vaccination site pain) (latency- same day) following the administration of influenza quadrival a-b high dose hv vaccine.  It was reported Patient said her left arm where the shot was administered started hurting 1 week after she got the shot. Patient said it happens on and off during the day and the pain wakes her up at night from her sleep. Patient said it is not on the outside that hurts (sore) but from the inside of her arm where the shot was administered.  Action taken- Not applicable.  It was not reported if the patient received a corrective treatment for the event (vaccination site pain).  At time of reporting, the outcome was Not Recovered / Not Resolved.
Fever, hallucinations, pain at injection site, body aches. Hallucinations lasted around an hour.
aching; feeling crappy; feeling lousy/feeling sick almost 3 weeks after 1st dose; have a low grade fever; This is a spontaneous report from a contactable consumer (Patient). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection; Lot number and expiration date was not reported), dose 1 via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 21Apr2021, 3 weeks after receiving first dose, patient experienced aching, feeling lousy, had a low-grade fever, feeling crappy and sick. The outcome of the events was unknown.   No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Persistent swollen lymph nodes in neck region. Persistent pain, discomfort, burning sensation in left arm and neck region
Information has been received from a health professional concerning a 5 year old female who on 09-Jun-1999 was vaccinated with a dose of varicella virus vaccine live. On 23-Apr-2003 the patient developed break-through chickenpox. It was unknown if medical attention was sought. No product quality complaint was noted. It was also noted that 12 other patients were vaccinated with a dose of varicella virus vaccine live and developed break-through chickenpox (WAES #0305USA00356 and 0304USA00585 through 0305USA00595). Additional information has been requested.
Patient felt injection was given too high on shoulder. Had swelling for 1 week after and still has knot at injection site. Still feels shoulder pain and numbness in his left hand. Not getting better
After the third day of my vaccine , I develop a small lump on my left size ,  i was feelin my skin because felt a weird painful feeling under my skin till i felt the lump .. has grow little bit more since that date. its painful to wear a seat belt when i am driving. My second dose was more painful that the first one and my left arm got swallowed a lot , got the chills and extreme fatigue. My fatigue has gone away but the lump still there, I do have a Dr,  appoittment  on May/12/21
10/30/19 @ 15:33: Pneumovax 23 administered. Pt was concerned the vaccine was administered too high on arm. Administration was very painful, and later that evening her arm became immobile. She couldn't sleep, nor cover her arm due to the pain (level 10). There is a 4 to 5 inch red, swollen area at and surrounding injection site.
Within 2 hours of taking the vaccine, I experienced tightness and weakness on my left side. My left eye and left side of my mouth tightening up as if I was having a stroke or some type of Paralysis like Bell's Palsy.  Prior to the left side  weakness/paralysis, it felt as if tiny balls or blood clots were going through my veins. I became very tired and as  a result, I took a nap. I was awakened by the "pulling sensation"  in my face. When I awakened, I couldn't speak correctly or open my left eye all the way.. My daughter researched and brought cold water to me. it helped. I am reporting this on the 3rd day after the event. I am currently suffering from wheezing, exhaustion, double vision and brain fog.
PATIENT INITIALLY EXPERIENCED MOTTLING OF THE SKIN SURROUNDING THE INJECTION SITE BY ABOUT 1-1.5 SQUARE INCHES. THE SKIN WAS BROWNED AND DISCOLORED, IN ADDITION TO THE NORMAL EXPECTED SWELLING AND HARDENING OF THE LOCAL TISSUE. SHE DID NOT EXPERIENCE BRUISING. SHE TOOK HERSELF TO THE EMERGENCY ROOM TO BE INSPECTED FOR A SKIN INFECTION AND WAS TOLD IT WAS CLEAR OF INFECTION. TODAY, 11/26/19, SHE CAME TO THE PHARMACY TO SHOW ME THE SKING. I CAN SEE SLIGHT SLOUGHING OF THE SKIN IN THE CENTER NEAR THE INJECTION SITE AND STILL NO ADDITIONAL SWELLING NOR SPREADING OF THE MOTTLING OF THE SKIN.
(L) arm - (?) reaction to MENACTRA red, warm, tense over deltoid.
Extreme light headness, weakness, fever 99.3 F, emotional, lethargic, general feeling of unwellness, chills, headache, muscle aches particularly head and neck and upper left arm around injection site, fever 99.5, two hours later fever was 100.3 and three hours after it was 100.5.  I called my primary care physician but no one returned my call.   Awoke around 2:21 am, I am moist, my fever had broken.  Feeling much better.  During this period I experienced intense anger which was troubling.  I though I had been given the virus rather than the vaccine.  I am experiencing a much better mood this morning.
experienced chills, body aches, nausea, headache and low grade fever aprx 5 hours subsequent to receiving vaccine. Following morning felt fine with some fatigue. Less disruptive symptoms included soreness at site of injection, and very sore axillary of arm adjacent to injection.
This case was reported by a consumer via call center representative and described the occurrence of allergic reaction in a 56-year-old female patient who received SHINGRIX for prophylaxis. Concomitant products included SHINGRIX. On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced allergic reaction. On an unknown date, the outcome of the allergic reaction was unknown. It was unknown if the reporter considered the allergic reaction to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported but it could be 55 or 56 years. The patient received both the doses of SHINGRIX and understand that it covers her for life. The patient wanted to know that what would be considered an allergic reaction to SHINGRIX other than the symptoms listed that would require immediate medical attention. The patient's pharmacist believed that she might had an allergic reaction to the 2nd dose of SHINGRIX. On the day of reporting patient had an appointment with physician. The patient has denied permission to contact her physician until she had spoken to the physician. The patient agreed to receive call back.
Patient reported urticaria and itching on multiple areas of her body that lasted about 5 days.  Patient also reported itching, redness, and swelling at the injection site for about 3 days.  She states that all this started the morning after the vaccine was administered.  She did not seek medical attention but was able to self-treat with Zyrtec and anti-itch cream.    Patient reports that the rash, some red streaks, and itching came back 1 and 1/2 weeks after the previous incidence but less severe this time.  She is self-treating with Zyrtec.    Patient's primary care physician has been notified of these adverse events.
This case was reported by a consumer via call center representative and described the occurrence of asthenia in a 79-year-old female patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX with an associated reaction of asthenia (1st dose received on 30th May 2018, refer case US2018193553). On 17th October 2018 16:00, the patient received the 2nd dose of SHINGRIX (intramuscular) .5 ml. In October 2018, 4 hrs after receiving SHINGRIX, the patient experienced asthenia, general body pain, injection site swelling, injection site erythema, sleepiness and influenza-like symptoms. Rechallenge with SHINGRIX was positive. On an unknown date, the outcome of the asthenia was not recovered/not resolved and the outcome of the general body pain, injection site swelling, injection site erythema and sleepiness were recovered/resolved and the outcome of the influenza-like symptoms was recovering/resolving. It was unknown if the reporter considered the asthenia, general body pain, injection site swelling, injection site erythema, sleepiness and influenza-like symptoms to be related to SHINGRIX. Additional details were provided as follows: The patient recevied SHINGRIX vaccine on left deltoid. Four to six hours after receiving vaccination, the patient experienced swelling and redness at the injection site, felt like she did not have energy, weakness, felt like she had the flu, was achy all over, and slept most of the day. The patient reported that the redness and swelling at the injection site was less after the 2nd dose of SHINGRIX. All of these symptoms had resolved except she was still feeling weak. She did feel that the weakness was resolving. The patient had denied permission to contact their physician.
generalized numbness and tingling down both arms extending from shoulders to fingers, transient sensation of bandlike chest tightening across rib cage, BP 156/94 with pulse oximetry 98, pulse 111. Observed one hour without allergic signs or symptoms and no wheezing.
Headache, muscle aches, fever, shivering, fatigue actually all listed 14 hrs after injection.
Parents report that within 5 minutes of getting vaccines, developed coughing, noisy breathing, and vomiting. Then developed flushing of his whole body with a couple red papules noted on his face, back, chest, and leg. No other medications given around this time and last food intake was 2 hours prior to event. Parents report that he got the vaccines around 4:20PM.
The day after, fatigue, headache and some chills. Then 2 days later, just the fatigue. Starting last Tuesday, I've broken out in hives. I've never had any skin reactions before. Also experienced some muscle twitching.
1/14/09 afternoon began chest pain. By Thurs. AM pain unbearable so went to ER. EKG normal & sent home. Fri. AM pain severe so went to ER. EKG & CXR normal. Given morphine & vicodan. Pain better but not gone.  Sat. PM went back to ER.  EKG & CXR normal. Given morphine and sent home.  Pain persisted throuigh 1/28/09.  Believes all of this was caused by the Hep B vaccination.
Received the booster of the Pfizer covid shot and the flu shot in the same day. Later that evening developed hives all over his body.
A female pt developed pain in the left deltoid and shoulder and numbness in the shoulder area after receiving RabAvert. The pt received five dose of RabAvert for post exposure prophylaxis. She complained of pain following injection into her left deltoid. Subsequently, doses three and four were administered into the gluteal area. Pain and numbness were also noted in the shoulder area, which had persisted for one year after RabAvert injections. The reporting physician stated the events were not related to RabAvert. He noted the subject may have a mechanical problem with her arm, causing the symptoms.
Presented for 3rd pre-exposure Rabies vaccine prior to heading down to work. He stated just after the needle was inserted he felt a sharp pain and burning sensation that didn't change when vaccine was administered. He stated he advised staff but felt he could leave. He went to the waiting room and noted his left arm pain was increasing and had a numb/tingling like sensation from top of shoulder down arm in a band-like fashion, over lateral side of elbow and stopped just on top of his wrist. Sensation did not extend to the fingers, dorsal surface or palmar surface of hand. He has no restrictions in ROM, grip, weakness; no true loss of sensation, no rash, edema, axillary pain, no chest pain, no neck pain, no other systemic symptoms. 1/9/2017 symptoms almost resolved now tingling only at vaccine site.
Patient received booster dose 2 days prior to 6 month mark.  No issues resulted at time of vaccination or during 15 minute observation period.